Regulatory Disclosures
Effective Date: 1 January 2025. The following disclosures are provided in accordance with applicable regulatory requirements and standard institutional practice. All persons accessing this website or engaging with Innekto Incorporated are required to read and consider these disclosures carefully.
IMPORTANT — READ CAREFULLY: This page contains material risk disclosures and regulatory notices applicable to all services provided by Innekto Incorporated and its affiliates. These disclosures do not constitute a comprehensive statement of all risks relevant to any particular transaction or engagement. Prospective clients must conduct their own independent assessment of risks and, where appropriate, consult qualified legal, financial, and tax advisors.
Informational Purposes Only
The information contained on this website and in any materials published or distributed by Innekto Incorporated is provided solely for general informational purposes and to describe the firm's capabilities and service offerings to eligible institutional recipients. It does not constitute, and should not be construed as, financial advice, investment advice, legal advice, tax advice, accounting advice, or any other form of professional or regulated advice or recommendation.
No representation is made that any information on this website is accurate, complete, or current. Market data, transaction references, indicative pricing, and capability statements are provided for illustrative purposes only and may not reflect prevailing market conditions at the time of access. Innekto assumes no obligation to update information following its initial publication.
Access to this website and the information contained herein does not create any client, advisory, fiduciary, or contractual relationship between Innekto Incorporated and any person or entity. An engagement relationship arises only upon execution of a written mandate agreement duly signed by authorised representatives of both parties.
Innekto Incorporated is not a registered investment adviser, broker-dealer, commodity pool operator, or commodity trading adviser under applicable US federal or state securities or commodities laws, except to the extent otherwise specifically indicated in connection with a particular service. Services described on this website may be subject to licensing and regulatory requirements that vary by jurisdiction.
Capital at Risk
All investment and advisory activities involve risk. The value of investments can fall as well as rise, and investors may receive back less than the amount originally committed. Past performance is not indicative of, and does not guarantee, future results. Forward-looking statements, indicative returns, target yields, and projected performance metrics presented in any Innekto materials represent estimates based on assumptions that may or may not prove to be correct, and actual outcomes may differ materially.
The following risk factors are representative of those commonly applicable to institutional investment and advisory mandates. This list is not exhaustive, and specific risks will vary depending on the nature, structure, and jurisdiction of any given engagement.
- ▸Values of financial instruments, commodity positions, and investment portfolios may fluctuate significantly due to market conditions, macroeconomic factors, geopolitical events, and regulatory changes that are outside our control.
- ▸Interest rate movements, currency fluctuations, and credit spread widening can each materially affect the value of financial positions and the economics of completed or pending transactions.
- ▸Liquidity conditions in financial markets can deteriorate rapidly. In illiquid or dislocated markets, positions may be impossible to exit at fair value or at all.
- ▸Counterparties in any transaction — including financial institutions, corporate borrowers, and sovereign entities — may default on their obligations. Credit quality can deteriorate without advance warning.
- ▸Debt instruments, including those arranged or underwritten by Innekto, carry credit risk. Recovery rates in distressed scenarios are uncertain and may be materially below par.
- ▸A significant portion of Innekto's advisory experience is concentrated in the healthcare, life sciences, specialty pharmaceuticals, and commodities sectors. Sector-specific factors including regulatory action, pricing pressure, clinical trial outcomes, and commodity supply/demand dynamics may affect the value of transactions in these areas disproportionately.
- ▸Many of the financing structures arranged by Innekto involve leverage, including acquisition financing, bridge facilities, and leveraged loans. Leverage amplifies both gains and losses, and highly leveraged entities face elevated risk of financial distress in adverse market conditions.
- ▸Covenant breaches, margin calls, and lender acceleration rights can force asset sales at disadvantageous prices.
Risks Specific to Commodities Markets
Innekto Incorporated is engaged in physical and financial commodities activities across precious metals, essential oils, and agricultural products. Commodities trading involves a distinctive and substantial set of risks that differ materially from those associated with conventional financial instruments. Institutional counterparties considering any commodities-related engagement should carefully assess the following:
- ▸Commodity prices are subject to extreme volatility driven by weather events, crop failures, geopolitical disruptions, changes in industrial demand, currency movements, and macroeconomic policy shifts. Price swings of 20–40% or more within a single contract period are not uncommon in certain commodity classes.
- ▸Precious metals prices are influenced by central bank gold policies, investor sentiment, inflation expectations, and US dollar strength — factors that are inherently difficult to predict with precision.
- ▸Essential oils and agricultural commodity prices are highly sensitive to seasonal supply factors, harvest quality, disease, and regulatory decisions affecting cultivation or export.
- ▸Physical commodity markets can be illiquid, particularly for specialised grades, proprietary blends, or products sourced from geographically constrained origins.
- ▸In periods of market stress, bid-offer spreads may widen materially, and the ability to execute large transactions at quoted prices may be severely limited.
- ▸Storage, transportation, insurance, and logistics costs associated with physical commodity positions represent real economic exposures that can erode transaction economics.
- ▸Physical commodity transactions involve settlement risk associated with delivery logistics, quality inspection, and the financial standing of the delivering counterparty.
- ▸Commodity trades executed with counterparties in emerging or frontier markets carry elevated sovereign, political, and regulatory risk that may impair enforcement of contractual rights.
- ▸International commodity trading is subject to a complex and evolving web of export controls, sanctions regimes, environmental regulations, and trade compliance requirements. Changes in applicable law or designation of counterparties under sanctions regimes can render pending or completed transactions non-executable or legally void.
Scope and Limitations of Advisory Services
Innekto Incorporated provides investment banking services on a private market basis exclusively. The firm does not provide, and has not provided, services related to initial public offerings, public equity listings, securities underwriting for public distribution, or any other services requiring registration as a broker-dealer with the US Securities and Exchange Commission or equivalent authorities in other jurisdictions, except where specifically licensed or exempted.
All investment banking mandates — including M&A advisory, capital raising, and structured finance — are subject to the following limitations and risk factors:
- ▸Innekto's role in any M&A or advisory transaction is as financial advisor only. We do not provide legal, accounting, actuarial, or tax advice, and our opinions do not substitute for the independent judgment of qualified advisors in those disciplines.
- ▸Fairness opinions and valuation analyses are based on information available at the time of preparation and the assumptions stated therein. They do not constitute a guarantee of value, and actual transaction outcomes may differ from the conclusions expressed.
- ▸Innekto does not conduct audit, verification, or independent due diligence of client-provided financial information unless specifically engaged to do so under a separate scope of work.
- ▸There is no guarantee that any M&A process, capital raising effort, or financing mandate managed by Innekto will result in a completed transaction. Market conditions, buyer/investor appetite, regulatory developments, and counterparty behaviour are all factors outside Innekto's control.
- ▸References to completed transactions in Innekto marketing materials reflect historical mandates and do not represent a guarantee of future results.
- ▸Innekto may from time to time be engaged in advisory or commercial relationships with parties that have interests adverse to, or differing from, those of a current client. Innekto maintains information barriers and conflict management policies designed to mitigate such risks, details of which are available upon request.
Healthcare, Life Sciences & Regulatory Advisory
Innekto Incorporated's consulting practice provides strategic and operational advisory services to clients in the healthcare, wellness, medical device, and life sciences sectors. All consulting services are advisory in nature only. The following limitations apply to all consulting engagements:
No Regulatory Guarantee: Innekto does not guarantee, represent, or warrant that any advice, strategy, or recommendation provided will result in regulatory approval, clearance, or authorisation from the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or any other national or supranational regulatory body. Regulatory outcomes are determined solely by the applicable regulatory authority, are inherently uncertain, and depend on factors beyond Innekto's knowledge or control.
No Medical or Clinical Advice: Innekto does not provide medical advice, clinical guidance, patient care recommendations, or physician-directed medical opinions. Nothing in our consulting services should be relied upon for clinical decision-making, and our advisory work is directed exclusively at the strategic, commercial, and regulatory dimensions of client businesses.
No Legal Advice: While our consulting practice may address regulatory strategy, including FDA submissions, device classification, and compliance pathways, such services are commercial advisory in nature and do not constitute legal advice. Clients requiring legal representation before regulatory authorities must retain qualified regulatory legal counsel independently.
Rapidly Evolving Regulatory Environment: Healthcare and medical device regulation is subject to frequent change. Guidance documents, regulations, and enforcement priorities may shift materially between the time advice is provided and the time it is acted upon. Innekto assumes no obligation to update advice previously given to reflect subsequent regulatory developments.
Geographic Scope and Regulatory Restrictions
This website is published by Innekto Incorporated from the United States and is intended to be accessed by institutional counterparties and qualified professional investors globally. However, the availability of particular services described on this website varies by jurisdiction and may be subject to restrictions imposed by applicable local law, regulation, or licensing requirements.
No Offer Where Prohibited: Nothing on this website constitutes an offer of, or solicitation for, services in any jurisdiction where such offer or solicitation is unlawful, requires additional licensing or registration that Innekto does not hold, or would subject Innekto to regulatory jurisdiction it has not consented to. Persons accessing this website from jurisdictions where its content would constitute a regulated communication are doing so on their own initiative and are solely responsible for compliance with applicable local laws.
United States: Certain investment banking and securities-related activities described on this website may be subject to US federal and state securities laws. Innekto Incorporated is not a registered broker-dealer with FINRA or the SEC, and investment banking services are provided on a private, exempt basis as permitted under applicable law.
United Arab Emirates: Innekto Global — FZCO is established in Dubai Silicon Oasis, a free zone in Dubai, UAE. Services provided through this entity are subject to the laws and regulations applicable in the UAE and the Dubai free zone framework. Activities involving financial services in the UAE are conducted in accordance with applicable UAE federal and emirate-level regulations.
European Economic Area and United Kingdom: Innekto is not authorised or regulated by the Financial Conduct Authority (FCA) in the United Kingdom or by any national competent authority within the European Economic Area under MiFID II or equivalent frameworks as a principal provider of investment services. Access to services by EEA and UK counterparties is subject to applicable regulatory exemptions and cross-border rules.
Innekto strongly recommends that prospective institutional clients consult qualified local legal counsel regarding the regulatory implications of engaging Innekto for services in their jurisdiction prior to initiating any engagement.
Caution Regarding Forward-Looking Information
Certain information contained on this website and in Innekto materials may constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements can often be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “intend,” “continue,” “believe,” “project,” “target,” “outlook,” or the negative of such terms or other variations thereof.
Forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other factors that are beyond Innekto's control, and actual results, performance, or achievements may differ materially from those expressed or implied in such statements. Factors that could cause actual outcomes to differ materially from any forward-looking statement include, without limitation:
Innekto undertakes no obligation to update, revise, or correct any forward-looking statement after its initial publication, whether as a result of new information, future events, or otherwise, except to the extent required by applicable law.
Recipients of any Innekto materials containing forward-looking information are cautioned not to place undue reliance on such statements. Forward-looking information is not a guarantee of future performance and should be considered together with the risk factors and limitations described throughout these Regulatory Disclosures.
Management of Potential Conflicts
Innekto Incorporated recognises that conflicts of interest may arise in the ordinary course of its business activities and is committed to managing such conflicts in a manner consistent with its fiduciary and contractual obligations to clients.
Potential sources of conflict include: simultaneous advisory roles on transactions involving parties on different sides of a negotiation; advisory relationships with entities that are, or may become, competitors of current clients; the receipt of fees from counterparties or capital providers in connection with transactions where Innekto also advises on the issuer or seller side; and the maintenance of commercial relationships in commodity markets where Innekto also provides advisory services.
Innekto manages these conflicts through: engagement-specific conflict screening prior to accepting mandates; information barriers between advisory and commercial teams where appropriate; written disclosure to clients of material conflicts identified prior to or during an engagement; and, where conflict cannot be adequately managed through other means, declining or withdrawing from the relevant mandate.
Clients who wish to receive further information regarding Innekto's conflicts management procedures may contact their relationship manager or write to compliance@innekto.com.
For questions regarding these disclosures, regulatory matters, or compliance-related enquiries, please contact:
The information presented on this page is intended for institutional counterparties and professional investors only. All references to target returns, yield strategies, and projected outcomes represent forward-looking estimates subject to material market, credit, liquidity, and operational risks. Past performance is not indicative of future results. Nothing herein constitutes an offer to buy or sell securities or investment products.